CY2025 Q3
| Company | Value | End Date | SEC Filing |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | $1,681,000,000.00 | 2025-09-30 | View |
| EDUCATIONAL DEVELOPMENT CORPORATION | $17,037,700.00 | 2025-08-31 | View |
| CRYO-CELL INTERNATIONAL, INC. | $4,864,834.00 | 2025-08-31 | View |
| BIOGEN INC. | $162,300,000.00 | 2025-09-30 | View |
| INCYTE CORPORATION | $366,510,000.00 | 2025-09-30 | View |
| AMARIN CORP PLC\UK | $9,106,000.00 | 2025-09-30 | View |
| THE BOSTON BEER COMPANY, INC. | $7,703,000.00 | 2025-09-27 | View |
| Stride, Inc. | $13,100,000.00 | 2025-09-30 | View |
| First Solar, Inc. | $254,541,000.00 | 2025-09-30 | View |
| VANDA PHARMACEUTICALS INC. | $7,997,000.00 | 2025-09-30 | View |
| ORION GROUP HOLDINGS, INC. | $6,862,000.00 | 2025-09-30 | View |
| ARDELYX, INC. | $104,186,000.00 | 2025-09-30 | View |
| TRAVERE THERAPEUTICS, INC. | $31,999,000.00 | 2025-09-30 | View |
| APELLIS PHARMACEUTICALS, INC. | $40,909,000.00 | 2025-09-30 | View |
| Indivior PLC | $1,000,000.00 | 2025-09-30 | View |
| RIBBON COMMUNICATIONS INC. | $16,846,000.00 | 2025-09-30 | View |
| FOX CORPORATION | $853,000,000.00 | 2025-09-30 | View |
| PHATHOM PHARMACEUTICALS, INC. | $24,101,000.00 | 2025-09-30 | View |
| GE HEALTHCARE TECHNOLOGIES INC. | $140,000,000.00 | 2025-09-30 | View |
SEC Filings Explorer
Formalu provides easy access to SEC filings and reporting data
Most Recent Filings
2000 most recent SEC filings for the current official filing date
Browse By Company
All SEC filings and reported GAAP facts from 2010 to now for every company
Formalu's Securities and Exchange Commission Page
SEC forms, contact information and locations